Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Clinical trial NCT07262567 · RECRUITING
Trial details
- NCT number
- NCT07262567
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-04
- Primary completion
- 2027-06-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.